期刊文献+

川楝素对乳腺癌MDA-MB-231细胞增殖的抑制作用 被引量:6

Inhibitory effect of toosendanin on growth of human breast cancer cells
原文传递
导出
摘要 目的探讨川楝素对人三阴性乳腺癌MDA-MB-231细胞生长的抑制作用及其机制。方法取对数生长期的MDA-MB-231细胞,采用0、6.25、12.50、25.00、50.00和100.00nmol/L川楝素处理,绘制生长曲线。川楝素0、12.5和50nmol/L处理72h后,采用MTS法检测川楝素对MDA-MB-231细胞增殖,流式细胞仪检测乳腺癌细胞凋亡和周期,Western blot检测凋亡相关蛋白半胱氨酶蛋白酶3(Caspase-3)、聚腺苷酸二磷酸核糖转移酶(PARP)和cleaved-PARP表达。结果川楝素呈时间和剂量依赖性抑制MDA-MB-231乳腺癌细胞增殖(P<0.01)。川楝素作用48、72和96h的半数抑制浓度(IC50)分别为9.32、16.96和122.37nmol/L。川楝素能呈浓度依赖性诱导乳腺癌细胞凋亡(P<0.01),阻滞细胞在S期(P<0.01)。以0、12.50和50.00nmol/L川楝素处理MDA-MB-231细胞72h,其早期凋亡率分别为8.12%、20.85%和67.21%,处于细胞周期S期的细胞占32.69%、47.90%和61.23%,凋亡相关蛋白Caspase-3和PARP减少,cleaved-PARP增多。结论川楝素对人乳腺癌MDA-MB-231细胞增殖具有抑制作用;其机制可能与诱导细胞凋亡和引起细胞S期阻滞有关。 Objective To explore the inhibitory effect of toosendanin on the growth of human breast cancer cell line MDA-MB-231 cells and its possible mechanism. Methods The MDA-MB-231 cell growth curve was drawn by treating the cells in logarithmic growth phase with different concentrations of toosendanin 0,6.25,12. 50,25.00,50.00 and 100. 00 nmol/L. After treating the cells with toosendanin 0,12.5 and 50 umol/L for 72 hours, the effect of toosendanin on the proliferation of MDA-MB-231 cells was observed with MTS assay, cell apoptosis and cycle were measured by flow cytometry, and the expressions of Caspase-3, PARP and cleaved-PARP were detected by Western blot. Results The proliferation of MDA-MB-231 cells was significantly inhibited by toosendanin in the dose- and time-dependent manners (P〈0. 01 ). The half inhibitory cencentrations (IC50) were 9.32 nmol/L,16. 96 nmol/L and 122. 37 nmol/L for the treating times of 48 hours,72 hours and 96 hours, respectively. Toosendanin inhibited the apoptosis of MDA-MB-231 cells in a concentration-dependent manner(P〈0.01) and blocked them in S phase. The expressions of Caspase-3 and PARP were decreased, but cleaved-PARP expression was increased. Conclusion Toosendanin can inhibit the growth of breast cancer cells, which is possibly related to inducing cell apoptosis and bloching cell cycle in S-phase.
出处 《江苏医药》 CAS 2015年第11期1255-1257,F0002,共4页 Jiangsu Medical Journal
基金 浙江省自然科学基金(Y2101312) 浙江省医药卫生科技计划(2010QNA006 2011RCB009 2005RCB005) 浙江省中医药科学研究基金计划(2011ZA014 2013ZB022 2014ZB019)
关键词 川楝素 乳腺癌 MDA-MB-231细胞 Toosendanin Breast cancer MDA-MB-231 cells
  • 相关文献

参考文献11

  • 1舒国欣,梁晓天.关于川楝素的化学结构的修正[J].化学学报,1980,38(2):196-198.
  • 2施玉樑,汤勉芝.细胞的死亡和川楝素的诱发凋亡作用[J].中国神经科学杂志,2004,20(6):461-465. 被引量:12
  • 3Tang MZ,Wang ZF,Shi YL.Involvement of cytochromec release and Caspase activation in toosendanin-induced PC12cell apoptosis[J].Toxicology,2004,201(1-3):31-38.
  • 4Tang MZ,Wang ZF,Shi YL.Toosendanin induces outgrowth of neuronal processes and apoptsis in PC12cells[J].Neurosci Res,2003,45(2):225-231.
  • 5王进,刘小玲,王鹏,蒋冬韵,何於娟.川楝素对K562细胞增殖和凋亡作用的影响[J].第四军医大学学报,2009,30(22):2528-2532. 被引量:12
  • 6He YJ,Wang J,Liu XL,et al.Toosendanin inhibits hepatocellular carcinoma cells by inducing mitochondria-dependent apoptosis[J].Planta Med,2010,76(13):1447-1453.
  • 7蔡锦威,汤海标,邵喜英,金洪传,毛伟敏,王晓稼.川楝素对乳腺癌细胞的生长抑制作用[J].中国肿瘤,2014,23(4):342-345. 被引量:8
  • 8Sunil S,Anil V,Danielle A,et al.Prognostic implications of cell cycle,apoptosis,and angiogenesis biomarkers in non-small cell lung cancer[J].Clin Cancer Res,2005,11(11):3974-3986.
  • 9Evan GI,Vousden KH.Proliferation,cell cycle and apoptosis in cancer[J].Nature,2001,411(6835):342-348.
  • 10Hajra KM,Liu JR.Apoptosome dysfunction in human cancer[J].Apoptosis,2004,9(6):691-704.

二级参考文献26

  • 1施玉樑,汤勉芝.细胞的死亡和川楝素的诱发凋亡作用[J].中国神经科学杂志,2004,20(6):461-465. 被引量:12
  • 2施玉樑,王文萍.驱蛔中药的活性成分川楝素的生物效应[J].生理学报,2006,58(5):397-406. 被引量:20
  • 3Zhang YH, Qi XM, Gong LK, et al. Roles of reactive oxygen species and MAP kinases in the primary rat heptocytes death induced by toosendanin[ J]. Toxicology ,2008 ,249 :62 - 68.
  • 4Efferth T, Kahl S, Paulus K, et al. Phytochemistry and pharmacogenomics of natural products derived from traditional chinese medicine and chinese materia medical with activity against tumor cells [ J ]. Mol Cancer,2008,7 : 152 - 161.
  • 5Carlo MC. Oncogenes and cancer[ J ]. N Engl J Med,2008,358: 502 -511.
  • 6Kimiko K, Michiko N, Shun A, et al. Caspase-8 mediates mitochondrial release of pro-apoptotic proteins in a manner independent of its proteolytic activity in apoptosis induced by the protein synthesis inhibitor acetoxycycloheximide in human leukemia jurkat cells [ J ]. J Biol Chem,2009,284 ( 9 ) :5478 - 5487.
  • 7Tang MZ, Wang ZF, Shi YL. Involvement of cytochrome C release and caspase activation in toosendanin-induced PCI2 cell apoptosis [J]. Toxicology,2004,201:31 -38.
  • 8Li MF, Shi YL. The long-term effect of toosendanin on current through nifedipine-sensitive Ca^2 + channels in NG108-15 cells [ J ]. Toxicon ,2005,45:53 - 60.
  • 9Zhai DY, Jin CF, Huang ZW. Differential regulation of bax and bak by anti-apoptotic bcl-2-family proteins, bcl-B and mcl-1 [ J]. J Biol Chem ,2008,15:9580 - 9586.
  • 10Kadohara K, Nagumo M, Asami S. Caspase-8 mediates mitochondrial release of pro-apoptotic proteins in a manner independent of its proteolytic activity in apoptosis induced by the protein synthesis inhibitor acetoxycycloheximide in human leukemia Jurkat cells [ J ]. J Biol Chem,2009,284:5478 -5487.

共引文献28

同被引文献94

引证文献6

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部